ABTI OTC
Alterola Biotech, Inc.
1W: +0.0%
1M: +0.0%
3M: -96.1%
YTD: -96.1%
1Y: +0.0%
3Y: -99.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
-2444.8% ▼
Capital Expenditures
$140K
+0.0% ▲
Free Cash Flow
-$1M
-2760.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$55K
-186.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$133K | -$259K | -$251K | -$6M | -$2M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $137K |
| Stock-Based Comp. | $54K | $126K | $130K | $0 | $802K |
| Change in Working Capital | $59K | $133K | $121K | $756K | -$35K |
| Other Non-Cash Items | $0 | $0 | $0 | $6M | -$12K |
| Operating Cash Flow | -$20K | $0 | $0 | $44K | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$140K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | -$140K |
| — Financing Activities — | |||||
| Net Debt Issuance | — | — | — | — | — |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $20K | $0 | $0 | -$378K | $1M |
| Financing Cash Flow | $20K | $0 | $0 | -$10K | $1M |
| Net Change in Cash | $0 | $0 | $0 | $63K | -$55K |
| Cash End of Period | $0 | $0 | $0 | $64K | $9K |
| Free Cash Flow | -$20K | $0 | $0 | $44K | -$1M |